U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07606378) titled 'Efficacy of PRP Injections in Reducing Pain for Myogenous TMD Patients' on May 19.
Brief Summary: This study aims to evaluate whether intramuscular injections of platelet-rich plasma (PRP) are more effective than isotonic saline in reducing pain and improving jaw function in individuals diagnosed with myogenous temporomandibular disorders (TMD). Myogenous TMD is a common source of orofacial muscle pain and functional limitation, and although conservative treatments help many patients, a significant proportion continue to experience persistent symptoms that affect daily life and quality of function.
PRP is an autologous, minimally in...